multiple myeloma
Conditions
Interventions
The patients dissolve TJ-14(2.5 g) in 50-100 ml of water and rinse their oral cavity with the solution three times daily for 10 seconds from chemotherapy to 3 days after engraftment.
The patients do s
Sponsors
Hitachi general hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who undergo autologous stem cell transplantation ECOG-Performance Status (PS) is 0-2. Patients who are not allergic to Kanpo Patient who provided written consents for this study.
Exclusion criteria
Exclusion criteria: Uncontrolled active infection. Active gastrointestinal ulcer. Uncontrolled diabetes mellitus. Serious psychiatric illness. Patient who is judged to be medically unfit by physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of diarrhea grade 2 or higher between the TJ-14 group and control group in the period from transplantation to engraftment | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of diarrhea in each grade The incidence of mucositis oral in each grade The period of appearance of diarrhea of Grade 2 or higher The period of appearance of mucositis oral of Grade 2 or higher Differences Alb between before chemotherapy and engraftment | — |
Countries
Japan
Contacts
Public ContactTakuya Suyama
Hitachi general hospital hematology,oncology
Outcome results
None listed